Keywords: nice, approves, mabthera, first-line, therapy, nhl, uk

NICE approves MabThera as first-line therapy for NHL

Article | 02 October 2006

Print This

The UK's National Institute for Health and Clinical Excellence (NICE), the body that evaluates drugs for the National Health Service ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in